Scientist II
Gene Editing, Durham
Confirmed live in the last 24 hours
ReCode Therapeutics

51-200 employees

Develops targeted mRNA and gene correction therapeutics
Company Overview
ReCode Therapeutics, a clinical-stage genetic medicines company, distinguishes itself through its proprietary selective organ targeting (SORT) lipid nanoparticle (LNP) platform, a technology that enables precise delivery of genetic medicines to target organs and cells beyond the liver. The company's leadership, including Ms. Jefferson, boasts extensive experience in biopharma and public health communications, with a track record of strategic roles at the U.S. FDA and other notable biopharma companies. This blend of technical prowess and industry leadership positions ReCode Therapeutics as a competitive player in the genetic medicines field.
Data & Analytics

Company Stage

Series B

Total Funding





Menlo Park, California

Growth & Insights

6 month growth


1 year growth


2 year growth

Durham, NC, USA
Experience Level
Desired Skills
Biology & Biotech
  • PhD in molecular biology, cell biology, biological engineering or related discipline with 4 years of experience in postdoctoral research and/or industry
  • Subject matter expertise, with a proven track record of publications/patents, in gene editing, with a broad knowledge of gene editing applications for therapeutic drug development
  • Hands-on experience using gene editing tools including first and second generation CRISPR systems; and knowledge of associated analytic assays (e.g. Western blot, ddPCR, qPCR), including NGS methods for interrogating editing outcomes
  • Experience in mammalian cell and tissue culturing is required
  • Prior working experience with primary human cell culture and/or non-human primate/murine preclinical disease models and related experimental work (recommended)
  • Prior experience in a BSL2 or more environment (recommended)
  • Understanding of lung biology and/or rare lung disease (recommended)
  • Experience with viral or non-viral delivery platforms, preferably lipid nanoparticles (LNPs)
  • Excellent verbal and written communication skills, with proven ability to write reports and/or articles for publication
  • Advanced knowledge of statistical and genome analytical tools (GraphPad, R, SnapGene)
  • Excellent project leadership skills in driving for results and innovation; ability to execute within a matrixed organization
  • Extremely organized and able to efficiently manage your time and workflow, including skillfully prioritizing both long-term projects and day-to-day responsibilities
  • Highly collaborative, team-oriented, and considerate of the needs of others
  • Desire to work in a fast-paced environment and contribute to developing the next generation of gene editing
  • Lead, design, and optimize research with the aims of exploring and developing next-generation gene editing therapies
  • Design, execute, and interpret research in primary cell cultures and/or in vivo disease models; establish cell-based and/or biochemical assays for validating biological activity of novel gene-editing medicines; design and execute NGS/ddPCR assays for measuring on-target editing outcomes
  • Generate, manage, evaluate, and maintain critical data in a highly organized manner, providing statistical analysis and troubleshooting where appropriate
  • Analyze and present experimental data to a wide range of audiences
  • Trouble shoot and dissect published literature to find novel solutions to resolve technical and/or biological hurdles
  • Contribute as a key member of a cross functional drug discovery team that includes gene correction, primary human biology, pharmacology, computational biology, bioanalytical, toxicology and formulation capabilities
  • Prepare SOPs, keep excellent electronic lab notebook and record keeping entries, and prepare reports and/or manuscripts for publication